Metastatic Pancreatic Cancer
4 competing products in clinical development for Metastatic Pancreatic Cancer.
Pipeline by Phase
Phase 13
Phase 21
All Products (4)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| ONO-7475 + ONO-4538 + Nab-paclitaxel + Gemcitabine | Ono Pharmaceutical | Phase 1 | Active | 33 |
| ONO-7913 + ONO-4538 + Oxaliplatin + Levofolinate + Irinotecan + Fluorouracil | Ono Pharmaceutical | Phase 1 | Active | 33 |
| ONO-4578 + ONO-4538 + Oxaliplatin + Levofolinate + Irinotecan + Fluorouracil + Gemcitabine + Nab-Paclitaxel | Ono Pharmaceutical | Phase 1 | Completed | 29 |
| Ontak | Eisai | Phase 2 | Terminated | 27 |